Desoxyn is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases Inc.. The primary component is Methamphetamine Hydrochloride.
Product ID | 55292-104_5da833ac-8405-47f7-8cdc-fba46ec1719a |
NDC | 55292-104 |
Product Type | Human Prescription Drug |
Proprietary Name | Desoxyn |
Generic Name | Methamphetamine Hydrochloride |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1943-12-31 |
Marketing End Date | 2022-12-11 |
Marketing Category | NDA / NDA |
Application Number | NDA005378 |
Labeler Name | Recordati Rare Diseases Inc. |
Substance Name | METHAMPHETAMINE HYDROCHLORIDE |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Amphetamine Anorectic [EPC], Amphetamines [CS], Appetite Suppression [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE] |
DEA Schedule | CII |
NDC Exclude Flag | N |
Marketing Start Date | 1943-12-31 |
Marketing End Date | 2022-12-11 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA005378 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1943-12-31 |
Ingredient | Strength |
---|---|
METHAMPHETAMINE HYDROCHLORIDE | 5 mg/1 |
SPL SET ID: | f03a68d5-ed00-8a2d-af68-28be909ea85f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
55292-104 | Desoxyn | methamphetamine hydrochloride |
70868-820 | Desoxyn | methamphetamine hydrochloride |
0054-0389 | Methamphetamine Hydrochloride | Methamphetamine Hydrochloride |
68308-115 | Methamphetamine Hydrochloride | METHAMPHETAMINE HYDROCHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
DESOXYN 97563029 not registered Live/Pending |
Seven Oaks Pharma, LLC 2022-08-24 |
DESOXYN 73727187 1521495 Live/Registered |
ABBOTT LABORATORIES 1988-05-09 |
DESOXYN 71465771 0434257 Dead/Expired |
ABBOTT LABORATORIES 1943-12-15 |